Article
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing
6 Oct 2017
Abstract excerpt
BACKGROUND: Noninvasive prenatal testing (NIPT) uses cell-free DNA (cfDNA) as an analyte to detect copy-number alterations in the fetal genome. Because maternal and fetal cfDNA contributions are comingled, changes in the maternal genome can manifest as abnormal NIPT results. Circulating tumor DNA (ctDNA) present in cases of maternal neoplasia has the potential to distort the NIPT readout to a degree that prevents...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
